About ZEUSQQ
ZEUSQQ is a Healthcare company based in San Francisco (United States) founded in 2016, and was acquired by Active Motif in January 2022. RNA sequencing technology is developed for diagnostics and development applications. It operates on a Pay-per-Use / Usage-Based model. ZEUSQQ has raised $250 thousand across 1 funding round from investors including Active Motif and IndieBio. ZEUSQQ offers products and services including Zeus Slot. Its focus areas include Entertainment, Gambling and Online Casinos. Its competitors include Omniome, Tessera Therapeutics and Phase Genomics; 3 of its 3 listed competitors have raised funding.
Company details
ZEUSQQ is managed as an online gambling platform specializing in slot games. Focus is placed on the Zeus Slot, inspired by Greek mythology, featuring themes like Mount Olympus and symbols such as Zeuss lightning. Strategies and tips for maximizing jackpot wins are provided to users. The platform is designed for user comfort and security, targeting online casino enthusiasts globally.
- Headquarters San Francisco, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website amaryllisnucleics.com
- Social LinkedIn X
- Acquired by Active Motif (Jan 2022)
- Total Equity Funding$250K (USD)
in 1 rounds
- Latest Funding Round$250K (USD), Seed
Mar 2016
- InvestorsActive Motif
& 1 more
- Acquired byActive Motif
(Jan 2022)
Products & Services of ZEUSQQ
ZEUSQQ offers a comprehensive portfolio of products and services, including Zeus Slot.
Online slot game with Greek mythology theme offered.
Funding Insights of ZEUSQQ
ZEUSQQ has successfully raised a total of $250K through 1 strategic funding round. The most recent funding activity was a Seed round of $250 thousand completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $250,000
- Total Rounds 1
- Last Round Seed — $250,000
- First Round $250,000
(Mar 2016)
- Investors Count 1
All 1 funding rounds of ZEUSQQ with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2016 | $250,000 | Seed | – | IndieBio | – |
2 investors in total: 2 institutional.
Investors in ZEUSQQ
ZEUSQQ has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Active Motif and IndieBio.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Biotech startups are accelerated through IndieBio's focused programs. | indiebio.co | San Francisco, United States | ||
Epigenetics and gene regulation research tools are developed and distributed. | 1999 | activemotif.com | Carlsbad, United States |
Investor details for ZEUSQQ
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of ZEUSQQ
3 dated milestones of ZEUSQQ across 6 years, from founding to its latest funding, stage changes and deals.
- Founded ZEUSQQ is founded.
- Funding First funding round of $250K.
- Exit Acquired by Active Motif.
Competitors of ZEUSQQ
ZEUSQQ has 3 listed competitors in our database, 3 of them funded. They include Omniome, Tessera Therapeutics and Phase Genomics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| tesseratherapeutics.com | 2017 | Cambridge, United States | $610M | 149 | New genome engineering technology is provided for treating multiple diseases. | |
| phasegenomics.com | 2015 | Seattle, United States | $5.75M | 19 | Laboratory and computational services for DNA proximity analysis are provided. |
Detailed competitors of ZEUSQQ
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as ZEUSQQ (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zeusqq
Complete news archive for ZEUSQQ
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ZEUSQQ
ZEUSQQ was founded in 2016.
ZEUSQQ is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
ZEUSQQ is a funded company, having raised a total of $250K across 1 funding round to date. The company's 1st funding round was a Seed of $250K, raised on Mar 2016.
ZEUSQQ is managed as an online gambling platform specializing in slot games. Focus is placed on the Zeus Slot, inspired by Greek mythology, featuring themes like Mount Olympus and symbols such as Zeuss lightning. Strategies and tips for maximizing jackpot wins are provided to users. The platform is designed for user comfort and security, targeting online casino enthusiasts globally.
ZEUSQQ's top competitors include Tessera Therapeutics, Phase Genomics and Omniome.
ZEUSQQ offers Zeus Slot.
ZEUSQQ has 2 investors. Key investors include Active Motif, and IndieBio.
Yes. ZEUSQQ was acquired by Active Motif in January 2022.